Dr. Duduzile Ndwandwe, Clinical Trials,Best Researcher Award

Dr. Duduzile Ndwandwe, at Cochrane South Africa, South African Medical Research Council,South Africa

PROFILE

scopus

 

🎓Early Academic Pursuits :

Duduzile Ndwandwe was born in Waterval Boven, Mpumalanga, South Africa. Her academic journey began at Sikhulile Secondary School, where she completed her Matric Senior Certificate in 2001. She then pursued higher education at the University of Limpopo, earning a Bachelor of Science degree in 2006 with majors in Physiology and Microbiology. Following this, she completed her Bachelor of Science Honours in Microbiology in 2007. Her passion for scientific research and dedication to advancing her knowledge led her to the University of the Witwatersrand, where she obtained a Master of Science in Microbial Genetics in 2008. She continued her studies at the same institution, earning a PhD in Molecular Mycobacteriology in 2013. Duduzile further expanded her expertise with an International Masters in Vaccinology from the University of Lausanne in 2021 and an Advanced Vaccinology Course from the University of Geneva in 2022. In 2023, she completed a Management Development Programme at Stellenbosch University.

🏢Professional Endeavors :

Duduzile Ndwandwe’s professional career is marked by significant contributions to the fields of vaccinology and public health. She began her career as a Laboratory Assistant at the University of Limpopo in 2006 and then served as a Teaching Assistant at the University of the Witwatersrand in 2007. Her postdoctoral journey took her to the University of KwaZulu-Natal, where she worked as a Postdoctoral Research Fellow in the Department of Pharmacology from 2015 to 2016.

In 2013, Duduzile joined the South African Medical Research Council (SAMRC) as a Senior Scientist in the HIV Prevention Research Unit, a role she held until 2015. She then transitioned to the Wits Reproductive Health & HIV Institute as a Senior Researcher, where she led clinical trials such as HPTN 082 and EMPOWER from 2016 to 2017. Since 2021, Duduzile has been a Specialist Scientist at Cochrane South Africa, leading projects on Vaccine Implementation Research and Clinical Trial Registration. She also served as the Deputy Director of Cochrane South Africa from 2021 to 2024 and has been the Board Chair of Eh! Woza since 2019.

🔬Contributions and Research Focus :

Duduzile Ndwandwe’s research primarily focuses on vaccinology, clinical trials, and public health. She has been instrumental in leading and facilitating numerous projects that aim to improve vaccination implementation and clinical trial methodologies in Africa. Her work includes significant contributions to the South African National Clinical Trial Register and the Pan African Clinical Trial Register (PACTR). She has also been involved in projects funded by prominent organizations such as the National Research Foundation, EDCTP, and Oxford University, addressing critical health issues and enhancing research capacities in the region.

🏆Accolades and Recognition :

Duduzile’s outstanding contributions to science and public health have been recognized through various awards and scholarships. Notable among these are the International Masters in Vaccinology program scholarship from SAMRC (2018-2021) and the postdoctoral research scholarship from the University of KwaZulu-Natal in 2015. She was also a recipient of the prestigious Columbia University – Southern African Fogarty AIDS Training and Research Programme fellowship in 2010 and the Mellon Postgraduate Mentoring Scheme scholarship from the University of the Witwatersrand (2009-2011).

🌍Impact and Influence :

Throughout her career, Duduzile Ndwandwe has significantly impacted the scientific community and public health sector. Her research has led to improved methodologies in clinical trials and vaccination programs, enhancing transparency and accountability in clinical trial registrations across Africa. Her leadership roles in various research initiatives and institutions have fostered collaborations and capacity-building, driving progress in public health and vaccinology.

🔮Legacy and Future Contributions :

Duduzile Ndwandwe’s legacy is defined by her unwavering commitment to advancing scientific research and public health. Her work has laid the foundation for future research and interventions in vaccinology and clinical trials. She continues to influence upcoming scientists and public health professionals through her mentorship and leadership roles. As she progresses in her career, Duduzile remains dedicated to addressing global health challenges and contributing to the betterment of public health systems worldwide.

🎓Publication 

High-sensitivity C-reactive protein among people living with HIV on highly active antiretroviral therapy: a systemic review and meta-analysis

  • Authors   :Mabhida, S.E., Mchiza, Z.J., Mokgalaboni, K., Kengne, A.P., Dludla, P.V.
  • Journal    :MC Infectious Diseases
  • Year         :2024

The impact of DNA methylation as a factor of Adverse Pregnancy and Birth Outcomes (APBOs): a systematic review protocol

    • Authors :Moagi, I., Mabasa, L., Maputle, S.M., Malwela, T., Samie, A.
    • Journal   :Systematic Reviews
    • Year       : 2024

Global trends in clinical trials and interventions for the metabolic syndrome: A comprehensive analysis of the WHO International Clinical Trials platform

Peer learning in immunisation programmes

  • Authors  :Adamu, A.A., Ndwandwe, D., Jalo, R.I., Ndoutabe, M., Wiysonge, C.S.
  • Journal   :The Lancet
  • Year        :   2024

Cofinancing immunisation through national health insurance

Dr. Duduzile Ndwandwe| Clinical Trials|Best Researcher Award

You May Also Like